This story was originally published July 22.

Cancer Research UK has selected Illumina as a preferred service provider for whole-genome sequencing of cancer genomes as part of its contribution to the International Cancer Genome Consortium.

Illumina's sequencing services will first be applied toward prostate and esophageal cancers and will include whole-genome sequencing on the HiSeq 2000 of up to 1,500 samples over the next three years on both tumor and normal genomes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.